Literature DB >> 1772471

Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.

P H Winocour1, P N Durrington, D Bhatnagar, M Ishola, M Mackness, S Arrol.   

Abstract

The procedure of discontinuous gradient ultracentrifugation (DGU) was used to characterize the influence of early diabetic nephropathy on the composition of very low density lipoprotein (VLDL, flotation density 60-400 Svedberg (Sf) units), low density lipoprotein (LDL, flotation density 0-12 Sf) and subfractions of intermediate density lipoprotein (IDL1 and IDL2, 20-60 and 12-20 Sf, respectively). Forty-six subjects with type 1 (insulin-dependent) diabetes and serum creatinine, less than 140 mumol/l were studied, of whom 23 consistently had normal rates of albumin excretion (AER less than 15 micrograms/min), and 23 had persistent albuminuria (AER 20.0-960.6 micrograms/min). The two groups were similar with respect to total serum lipids, glycaemic control, age and body mass. The composition (lipid, protein and phospholipid) and mass of VLDL, LDL and IDL2 was not appreciably altered by early nephropathy, but free and total cholesterol concentration in IDL1 (Sf 20-60) was increased (total cholesterol 0.68 (0.09) (mean (SE)) vs. 0.47 (0.07) mmol/l, and free cholesterol 0.27 (0.04) vs. 0.17 (0.03) mmol/l, both P less than 0.05). The explanation of these findings was probably an accumulation in the circulation of the remnants of chylomicron metabolism and/or intermediates in the conversion from VLDL to IDL1. In addition, there was a decrease in serum high density lipoprotein (HDL) cholesterol in early nephropathy (1.27 (0.06) vs. 1.38 (0.10) mmol/l, P less than 0.05), due to a decrease in the HDL2 cholesterol subfraction (P less than 0.05). These findings may in part explain the increased risk of premature atherosclerosis associated with the development of albuminuria.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1772471     DOI: 10.1016/0021-9150(91)90006-o

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Microalbuminuria.

Authors:  P H Winocour
Journal:  BMJ       Date:  1992-05-09

Review 2.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

3.  Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.

Authors:  S D Sibley; J E Hokanson; M W Steffes; J Q Purnell; S M Marcovina; P A Cleary; J D Brunzell
Journal:  Diabetes Care       Date:  1999-07       Impact factor: 19.112

4.  CD36 expression and lipid metabolism following an oral glucose challenge in South Asians.

Authors:  Jeetesh V Patel; Amitava Banerjee; Silvia Montoro-Garcia; Eduard Shantsila; Mushfique Alam; Paul Flinders; Kathleen Al Houlton; Elizabeth A Hughes; Gregory Yh Lip; Paramjit S Gill
Journal:  World J Diabetes       Date:  2015-07-10

5.  Analysis of cholesterol levels in lipoprotein(a) with anion-exchange chromatography.

Authors:  Yuji Hirowatari; Hiroshi Yoshida; Hideo Kurosawa; Yuko Shimura; Hidekatsu Yanai; Norio Tada
Journal:  J Lipid Res       Date:  2009-10-30       Impact factor: 5.922

6.  Microalbuminuria in inflammatory bowel disease.

Authors:  N Mahmud; J Stinson; M A O'Connell; T J Mantle; P W Keeling; J Feely; D G Weir; D Kelleher
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

7.  LDL subclasses in IDDM patients: relation to diabetic nephropathy.

Authors:  S Lahdenperä; P H Groop; M Tilly-Kiesi; T Kuusi; T G Elliott; G C Viberti; M R Taskinen
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.